Sight Sciences (SGHT) Invested Capital (2020 - 2026)

Sight Sciences' Invested Capital history runs 7 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $3.8 million in Q1 2026; TTM through Mar 2026 was $44.1 million, a 12.05% increase from a year earlier, with the FY2025 full-year figure at $40.3 million, up 2.4% from the prior year.
• Invested Capital retreated to $3.8 million in Q1 2026 per SGHT's latest filing, from $40.3 million in the prior quarter.
• Across five years, Invested Capital topped out at $40.3 million in Q4 2025 and bottomed at $3.8 million in Q1 2026.
• The 5-year median for Invested Capital is $33.9 million (2023), against an average of $30.1 million.
• Across the five-year window, Invested Capital climbed 1.84% in 2023 and rose 16.0% in 2024, its largest moves.
• Year by year, Invested Capital stood at $33.3 million in 2022, then grew by 1.84% to $33.9 million in 2023, then advanced by 16.0% to $39.4 million in 2024, then rose by 2.4% to $40.3 million in 2025, then tumbled by 90.58% to $3.8 million in 2026.
• Per Business Quant, the three latest SGHT Invested Capital figures stand at $3.8 million (Q1 2026), $40.3 million (Q4 2025), and $39.4 million (Q4 2024).